癌症治療和生物治療的全球市場：按應用、治療類型、最終用戶和地區分類

全球癌症治療和生物治療市場規模預計將從 2024 年的 1,941.1 億美元增至 2031 年的 3,441 億美元，2024 年至 2031 年複合年成長率為 8.5%。

圖：2024 年按地區分類的癌症藥物和生物製品的全球市場佔有率(%)

癌症治療和生物治療是全球顯著成長的市場。雖然化療等傳統治療方法有其局限性，但新的生物療法和標靶治療正在徹底改變癌症治療。生物療法利用人體免疫系統的力量，並使用單株抗體和其他藥物來抑制癌細胞的生長。標靶治療專注於癌細胞中發現的特定分子標靶，這與化療不同，化療會影響所有快速分裂的正常細胞和癌細胞。隨著對癌症生物學認知的進步和技術創新，多種生物製藥和標靶治療已被開發並商業化。這些新的治療方法正在改善許多癌症患者的存活率和生活品質。

市場動態：

全球癌症治療和生物治療市場的成長是由全球癌症發病率上升、對個人化醫療的需求不斷成長、癌症藥物開發的研究經費增加、新的標靶治療和生物治療藥物的發布所帶來的。然而，開發生物製藥和標靶治療的高成本以及相關的技術挑戰正在限制市場成長。增加對新機制和聯合治療的研究和開發為市場擴張提供了機會。

本研究的主要特點

該報告對全球癌症治療和生物治療市場進行了詳細分析，並介紹了年複合成長率（CAGR%）已發布。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，對全球癌症治療和生物治療市場的主要企業進行概況分析。

主要企業包括羅氏、諾華、輝瑞、Astra Zeneca、GlaxoSmithKline Plc和艾伯維。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球癌症治療和生物治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

• 研究目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球癌症治療與生物治療市場 - 新型冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章全球癌症治療/生物治療市場：依應用分類（2019-2031）

• 血癌
• 肺癌
• 大腸直腸癌
• 攝護腺癌
• 子宮頸癌
• 頭頸癌
• 膠質母細胞瘤
• 惡性腦膜瘤
• 間皮瘤
• 惡性黑色素瘤
• 其他

第6章全球癌症治療與生物治療市場：依治療類型分類（2019-2031）

• 化療
• 放射治療
• 荷爾蒙療法
• 生物療法
• 其他

第7章 全球癌症治療/生物治療市場：依最終使用者分類（2019-2031）

• 醫院/診所
• 癌症護理中心
• 研究所
• 其他

第8章全球癌症治療與生物治療市場：按地區（2019-2031）

• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第9章 競爭格局

• 公司簡介
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Celgene Corporation
  • ELI Lilly and Company
  • Hoffmann-La Roche AG
  • EnGeneIC Ltd
  • Merck &Co Inc.
  • Novartis
  • Pfizer Inc.
  • Johnson &Johnson
  • AstraZeneca
  • Bristol-Myers Squibb
  • Biogen IDEC
  • Sanofi
  • Novartis AG
  • Roche
  • Schering-Plough
  • Gilead Sciences
  • Takeda Pharmaceutical Company

第10章分析師建議

• Wheel of Fortune
• 分析師觀點
• Coherent Opportunity Map（COM）

第11章 參考文獻與調查方法

• 參考
• 調查方法

The Global Cancer Therapeutics and Biotherapeutics Market is estimated to be valued at USD 194.11 Bn in 2024 and is expected to reach USD 344.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Figure. Global Cancer Therapeutics And Biotherapeutics Market Share (%), By Region 2024

Cancer therapeutics and biotherapeutics is a large and growing market globally. While conventional treatment options such as chemotherapy have limitations, newer biological and targeted therapies are revolutionizing cancer treatment. Biological therapies harness the power of the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal and cancerous cells. With advances in understanding cancer biology and technological innovations, a wide range of biologics and targeted therapies are being developed and commercialized. These newer therapeutic approaches have improved survival and quality of life for many cancer patients.

Market Dynamics:

The global cancer therapeutics and biotherapeutics market growth is driven by the rising global cancer burden, growing demand for personalized medicine, increasing research funding for cancer drug development, and launch of novel targeted and biological therapies. However, high developmental costs of biologics and targeted drugs along with associated technical challenges are restraining the market growth. Ongoing R&D for newer mechanisms and combination therapies provide opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global cancer therapeutics and biotherapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cancer therapeutics and biotherapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Roche, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline and AbbVie.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cancer therapeutics and biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapeutics and biotherapeutics market

Detailed Segmentation-

• By Application
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Breast Cancer
  • Cervical Cancer
  • Head and Neck Cancer
  • Giloblastoma
  • Malignant Meningioma
  • Mesothelioma
  • Melanoma
  • Others
• By Therapy Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Radiation Therapy
  • Hormone Therapy
  • Biotherapy
  • Others
• By End User
  • Hospitals & Clinics
  • Cancer Care Centers
  • Research Institutes
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Celgene Corporation
  • ELI Lilly and Company
  • Hoffmann-La Roche AG
  • EnGeneIC Ltd
  • Merck & Co Inc.
  • Novartis
  • Pfizer Inc.
  • Johnson & Johnson
  • AstraZeneca
  • Bristol-Myers Squibb
  • Biogen IDEC
  • Sanofi
  • Novartis AG
  • Roche
  • Schering-Plough
  • Gilead Sciences
  • Takeda Pharmaceutical Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By End Users
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cancer Therapeutics and Biotherapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cancer Therapeutics and Biotherapeutics Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Blood Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Colorectal Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Prostate Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cervical Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Head and Neck Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Giloblastoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Malignant Meningioma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Mesothelioma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Melanoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cancer Therapeutics and Biotherapeutics Market, By Therapy Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Radiation Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hormone Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cancer Therapeutics and Biotherapeutics Market, By End-User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cancer Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cancer Therapeutics and Biotherapeutics Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Clinical Applications, 2019
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb
  • Celgene Corporation
  • ELI Lilly and Company
  • Hoffmann-La Roche AG
  • EnGeneIC Ltd
  • Merck & Co Inc.
  • Novartis
  • Pfizer Inc.
  • Johnson & Johnson
  • AstraZeneca
  • Bristol-Myers Squibb
  • Biogen IDEC
  • Sanofi
  • Novartis AG
  • Roche
  • Schering-Plough
  • Gilead Sciences
  • Takeda Pharmaceutical Company

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact